← All Signals

🏥 FDA: K.C. Pharmaceuticals, Inc — Class II

healthcarebearishSource: FDA
88%Confidence
0Views
FDASource
2026-04-15Date

Summary

Dry eye relief products from K.C. Pharmaceuticals show sterility problems affecting Gericare, TopCare, and Rite Aid brands. The expanding list of affected products indicates serious quality control breakdowns at the manufacturing facility.

Actionable: Review all eye care products manufactured by K.C. Pharmaceuticals for potential quality issues.

AI Confidence: 88%

Data Points

firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productDry Eye Relief Eye Drops, (glycerin 0.2%, hypromellose 0.2% and polyethylene glycol 400 1%) 0.5 FL OZ (15 mL) bottles; a) GERI CARE, Distributed by:

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now